CompanyPrivateSeattle, WA

Digital Biotechnologies, Inc

SEC EDGAR ClinicalTrials.gov

10-QNov 4Latest SEC filing

Form DDec 31$12M sold

November 2026

Adaptive Biotechnologies posts Q3 profitability, raises full-year MRD revenue guidance

Nov 4Quarterly updateAdaptive Biotechnologies Corp